Partners Michele L. Buenafe and Maarika L. Kimbrell and of counsel Ariel Z. Seeley were quoted in Law360 following a session of Morgan Lewis’s Technology Marathon series, where they examined the US Food and Drug Administration’s launch of an artificial intelligence (AI) tool and its new guidance on AI-enabled medical devices and drug development. The panel also addressed the agency’s expanding use of AI in policy and enforcement, including recent actions targeting wearable technology companies.
Read the full Law360 article >>
Subscription may be required.